FDA Inspection 1196868 — DyAnsys India Pvt. Ltd.
The FDA completed an inspection of DyAnsys India Pvt. Ltd. on December 15, 2022 in Chennai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 15, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Chennai (India)
Additional Details
Sponsor, Contract Research Organization